WHO releases updated guidance on national strategic planning for tuberculosis
Intergenerational Solidarity and adolescent wellbeing
Monkeypox: experts give virus variants new names
Vanuatu leads the way for Pacific elimination of trachoma – the world’s biggest infectious cause of blindness
Interim statement on COVID-19 vaccination for children
Now 7 million enrolments strong: Join the OpenWHO.org learning community
Launch of first WHO position paper on optimizing brain health across life
Global Report on Assistive Technology: moving forward
WHO launches appeal to respond to urgent health needs in the greater Horn of Africa
New global alliance launched to end AIDS in children by 2030
After lengthy debate, Brazil’s Drink-Driving Law is fully ratified
Joint statement by UNICEF Executive Director Catherine Russell and WHO Director-General Dr Tedros Adhanom Ghebreyesus on the occasion of World Breastfeeding Week
Two more cases of HIV cure reported at AIDS 2022
Call for side events at the COP27 Health Pavilion (closed)
Congratulations to GISRS from the United States of America
GISRS laid the foundation for protection through collaboration
Sustaining integrated surveillance in South-East Asia
70 years of GISRS, decades of collaboration
Regional gatherings to strengthen pandemic influenza preparedness
Afghanistan influenza surveillance system stands solid
WHO publishes new guidelines on HIV, hepatitis and STIs for key populations
WHO and UNAIDS support countries to introduce virtual interventions and HIV self-testing
WHO consultation on guidance development for conducting TB programme reviews
WHO recommends long-acting cabotegravir for HIV prevention
WHO applauds agreement to scale-up generic manufacturing for access to long-acting injectable antiretrovirals
HIV response under threat – new figures
Building a community of learning for women leaders in health emergencies
New US$ 1 price for HIV self-tests
WHO launched new implementation guidance for simplified and differentiated service delivery of pre-exposure prophylaxis (PrEP)
Guidance, tools and support for countries transitioning to digital, case-based surveillance for TB
